https://www.selleckchem.com/pr....oducts/pf-3644022.ht
Cardiovascular adverse events (hypertension, myocardial infarction, transient ischemic attack, tachycardia atrial fibrillation, and cerebrovascular accident) were reported. The meta-analysis demonstrated that duloxetine increased heart rate by 2.22 beats/min (95% confidence intervals [CIs] 1.53, 2.91) and diastolic blood pressure by 0.82 mmHg (95% CI 0.17, 1.47). Our findings may be the signal for the safety of cardiovascular disease for short-term use of duloxetine. Well-designed pharmaco-epidemiological studies evaluating the causa
Like
Comment
Share
